CCGA

New High-Density Ceramic Column Grid Array STT-MRAM Optimally Designed for Space and the Harshest Environments

Retrieved on: 
Friday, February 23, 2024
Transfer, CTE, READ, Architecture, SRAM, STT-MRAM, CBGA, Research, Swap, Temperature, PWA, IBM, CLGA, QML, MRAM, Palladium, Avalanche, CGA, Family, CCGA, Parallel, CLASP, WRITE, Printed circuit board

The Micross co-fired Ceramic Column Grid Array package is the latest addition to our Hi-Reliability MRAM solutions for Space applications that will benefit from improved thermal stress related, electro-mechanical failures.

Key Points: 
  • The Micross co-fired Ceramic Column Grid Array package is the latest addition to our Hi-Reliability MRAM solutions for Space applications that will benefit from improved thermal stress related, electro-mechanical failures.
  • This new package offering is made possible via our Column Last Attach Solder Process (CLASP), licensed from IBM promoting a highly robust thermal shock & stress survivability option for our Hermetic fine pitch packages.
  • Perpendicular Spin-Torque MRAM devices offer inherent protection from harsh environments, and the best power profile of all non-volatile memories – making them optimally suited for hi-reliability aerospace and space applications.
  • Micross' licensed CLASP column attach process utilizes a Sn10Pb90 solder wire that is attached to the parent Land Grid package via a eutectic Palladium doped Sn63Pb37 solder attach process.

Global Liquid Biopsy Market Report to 2027: Featuring Abbott Laboratories, AccuraGen, BGI Genomics and Biocartis Among Others - ResearchAndMarkets.com

Retrieved on: 
Thursday, December 1, 2022
Biotechnology, General Health, Health, Pharmaceutical, Oncology, Liquid biopsy, Recurrence, Diagnosis, CCGA, Price, Illumina, DNA, Prostate, Analysis, Exosome, Breakout 2000, Customization, COVID, Research, Lung, Medical imaging, Breast, Cancer

Including Executive and Consultant Guides and Customized Forecasting and Analysis 2023-2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • Including Executive and Consultant Guides and Customized Forecasting and Analysis 2023-2027" report has been added to ResearchAndMarkets.com's offering.
  • The Screening, Diagnostic, Therapy Selection, Recurrence Monitoring and Screening Market Potential are all explored in this report.
  • What is the impact of the COVID pandemic on the Liquid Biopsy market?
  • New technology that definitively identifies disease conditions from blood samples is poised to replace expensive invasive surgical biopsy procedures.

GRAIL CCGA Discovery Results Published in Cancer Cell Reveal Methylation as Promising DNA Hallmark for Multi-Cancer Early Detection

Retrieved on: 
Thursday, November 17, 2022
Oncology, Health, Health Technology, Genetics, Research, Science, Biotechnology, Patient, Prostate-specific antigen, Cervical cancer, Blood, Ageing, Data science, Manuscript, United Kingdom, European Commission, College of American Pathologists, Senior, Methylation, European Society of Gynaecological Oncology, Nucleic acid thermodynamics, Annals of Oncology, Mammography, Machine learning, Clinical Laboratory, Criterion, Cloud computing, DNA, PSA, Cancer, Illumina, Inc., CCGA, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Mortality, Colonoscopy, American Joint Committee on Cancer, CLIA, College, Diagnosis, Oncology, Somatic mutation, Clod, Risk, Food, Medical imaging, Cancer cell, The McLoughlin Gallery, GRAIL

Findings were published online in Cancer Cell in a manuscript titled Evaluation of Cell-Free DNA Approaches for Multi-Cancer Early Detection.

Key Points: 
  • Findings were published online in Cancer Cell in a manuscript titled Evaluation of Cell-Free DNA Approaches for Multi-Cancer Early Detection.
  • The CCGA Discovery Substudy showed that among the evaluated classifiers, those using whole-genome methylation had one of the highest cancer signal detection sensitivities at 98% specificity.
  • Notably, CCGA Discovery identified methylation features in ct-DNA as having the leading combination of cancer detection and cancer signal origin performance.
  • False-positive (a cancer signal detected when cancer is not present) and false-negative (a cancer signal not detected when cancer is present) test results do occur.

PelicanCorp to Appear at the Canadian Common Ground Alliance Damage Prevention Symposium

Retrieved on: 
Tuesday, October 25, 2022
Risk management, LinkedIn, News, Time, Risk, Telecommunication, Conference, Solution, Fairmont, Symposium, Technology, Human, Industry, CEO, Water, GLOBE, Accidental damage of art, Call centre, Young Global Leaders, CCGA, Civil engineering

IRVINE, Calif., Oct. 25, 2022 (GLOBE NEWSWIRE) -- PelicanCorp, the global leader in the damage prevention industry, is scheduled to take part in multiple panels at the Canadian Common Ground Alliance (CCGA) Damage Prevention Symposium.

Key Points: 
  • IRVINE, Calif., Oct. 25, 2022 (GLOBE NEWSWIRE) -- PelicanCorp, the global leader in the damage prevention industry, is scheduled to take part in multiple panels at the Canadian Common Ground Alliance (CCGA) Damage Prevention Symposium.
  • The CCGA Symposium is a signature event, attracting hundreds of damage prevention management professionals and decision-makers from across Canada.
  • The CCGA Symposium presents a unique opportunity to meet with Canadian and North American damage prevention industry professionals."
  • The Canadian Common Ground Alliance is focused on maximizing the value of this dynamic and engaging event for its attendees, providing practical, relevant information on damage prevention and public awareness initiatives.

Bankai Group Wins 'Best Innovative Software Provider' for 2021 at the CC-Global Awards, Berlin

Retrieved on: 
Wednesday, July 6, 2022
Acquisition, Telco, Solution, Pluto, CEO, CCGA, Telecommunication, ICT, Industry, Digital, Automation, DID, Software, List of Soul Reapers in Bleach, Teleco, CC, Leadership, Video game, Mobile phone

CCGA named Bankai's BridgeVoice Pluto the 'Best Innovative Software Provider' for 2021 .

Key Points: 
  • CCGA named Bankai's BridgeVoice Pluto the 'Best Innovative Software Provider' for 2021 .
  • The best of the Telco industry - professionals and services, were recognized for their achievements in 70+ categories, including innovations, achievements, leadership, and promising-future professionals.
  • Mr. Bankim Brahmbhatt, CEO of Bankai Group, said, "Receiving this award is a great honor.
  • For the past 33+ years, Bankai Group has been a leader in the ICT and services industry, specializing in voice telecom technology and wholesale & retail voice business.

Bankai Group Wins 'Best Innovative Software Provider' for 2021 at the CC-Global Awards, Berlin

Retrieved on: 
Wednesday, July 6, 2022
Acquisition, Telco, Solution, Pluto, CEO, CCGA, Telecommunication, ICT, Industry, Digital, Automation, DID, Software, List of Soul Reapers in Bleach, Teleco, CC, Leadership, Video game, Mobile phone

CCGA named Bankai's BridgeVoice Pluto the 'Best Innovative Software Provider' for 2021 .

Key Points: 
  • CCGA named Bankai's BridgeVoice Pluto the 'Best Innovative Software Provider' for 2021 .
  • The best of the Telco industry - professionals and services, were recognized for their achievements in 70+ categories, including innovations, achievements, leadership, and promising-future professionals.
  • Mr. Bankim Brahmbhatt, CEO of Bankai Group, said, "Receiving this award is a great honor.
  • For the past 33+ years, Bankai Group has been a leader in the ICT and services industry, specializing in voice telecom technology and wholesale & retail voice business.

World Liquid Biopsy Market Research Report 2022: Cancer, Usage, Biomarker, Place, & Product with Price and Volume Outlook Including Executive and Consultant Guides - ResearchAndMarkets.com

Retrieved on: 
Friday, March 25, 2022
Oncology, Health, Other Science, Pharmaceutical, Science, Biotechnology, Recurrence, Treatment, GRAIL, Lung, Prognosis, DNA, Diagnosis, Research, Prostate, Technology, Menarini, Price, Exosome, Breast cancer, Liquid biopsy, COVID, CCGA, Customization, Breakout 2000, Medical imaging, Cancer, Breast

The "Liquid Biopsy Markets by Cancer, Usage, Biomarker, Place, & Product With Price and Volume Outlook.

Key Points: 
  • The "Liquid Biopsy Markets by Cancer, Usage, Biomarker, Place, & Product With Price and Volume Outlook.
  • Including Executive and Consultant Guides and Customized Forecasting and Analysis" report has been added to ResearchAndMarkets.com's offering.
  • The Screening, Diagnostic, Therapy Selection, Recurrence Monitoring and Screening Market Potential are all explored in this report.
  • What is the impact of the COVID pandemic on the Liquid Biopsy market?

Global Liquid Biopsy Markets (by Cancer, Usage, Biomarker, Place & Product) 2021: Liquid Biopsy Enters Exponential Growth Phase as Pandemic Subsides - ResearchAndMarkets.com

Retrieved on: 
Monday, November 15, 2021
Biotechnology, Health, Oncology, Cancer, Breakout box, Prostate, Price, Technology, Lung, Liquid biopsy, COVID, Exosome, GRAIL, Recurrence, Customization, Diagnosis, Analysis, DNA, CCGA, Medical imaging

Including Executive and Consultant Guides and Customized Forecasting and Analysis 2022-2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • Including Executive and Consultant Guides and Customized Forecasting and Analysis 2022-2026" report has been added to ResearchAndMarkets.com's offering.
  • What is the impact of the COVID pandemic on the Liquid Biopsy market?
  • The new technology that definitively identifies disease conditions from blood samples is poised to replace expensive invasive surgical biopsy procedures.
  • The market is still in its infancy but has just moved out of the development phase and into the growth phase.

VYZYO Wins Carrier Community Global Award for Best Fintech Solution

Retrieved on: 
Wednesday, October 20, 2021
Government, Carrier, Smartphone, Technology, CAMPOST, Growth, Human, CCGA, Sale, SMS, Association, Internet, Nasdaq, Telecommunication, USSD, Science and technology in Asia, Industry, Group, Partnership, VAS, Population, Solution, Health, Airline, Mobile phone

LONDON, Oct. 20, 2021 /PRNewswire/ -- VYZYO , a rapidly growing mobile financial services technology company, today announced that the company has won the Carrier Community Global Award for Best Fintech Solution.

Key Points: 
  • LONDON, Oct. 20, 2021 /PRNewswire/ -- VYZYO , a rapidly growing mobile financial services technology company, today announced that the company has won the Carrier Community Global Award for Best Fintech Solution.
  • The Carrier Community is a global telecommunications industry networking association for wholesale telecom service providers and ecosystems partners.
  • In addition to winning the award for Best Fintech Solution at the award ceremony held last month in Berlin, VYZYO was also recognized by the Carrier Community with the Best Fastrack Award, which acknowledges the company's rapid growth over the past year.
  • Both regional and global operators came together at Carrier Community Global Awards to celebrate innovative achievements and the best players in the industry.

Liquid Biopsy Markets by Cancer Type and Usage Type with Impact of COVID-19 Pandemic, Q4 2021 Report - ResearchAndMarkets.com

Retrieved on: 
Tuesday, October 12, 2021
Biotechnology, Health, Oncology, Medical Devices, Exosome, Cdx, CCGA, COVID-19, Customization, COVID, Liquid biopsy, Recurrence, Diagnosis, Cancer, DNA, Analysis, GRAIL, Technology, Pharmaceutical industry

The "Liquid Biopsy Markets by Cancer Type and by Usage Type with Impact of COVID-19 Pandemic.

Key Points: 
  • The "Liquid Biopsy Markets by Cancer Type and by Usage Type with Impact of COVID-19 Pandemic.
  • The Screening, Diagnostic, Therapy Selection, Recurrence Monitoring and Screening Market Potential are all explored in this report.
  • What is the impact of the COVID pandemic on the Liquid Biopsy market?
  • In addition, the report looks at potential market sizes by country, by cancer and by the four types of usage: screening, diagnosis, therapy selection and recurrence monitoring.